Evidence map›Paper›PMID 34650837›Full record

ArticleCureus2021

Effect of Antibiotic Resistance of Pathogens on Initial Antibiotic Therapy for Patients With Cholangitis.

Sakue Masuda, Kazuya Koizumi, Haruki Uojima, Karen Kimura, Takashi Nishino, Junichi Tasaki, Chikamasa Ichita, Akiko Sasaki

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. ShortWorld journal of gastroenterology · 2023
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Comprehensive review on small common bile duct stones.World journal of gastroenterology · 2023
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sakue MasudaGastroenterology Medicine Center, Shonan Kamakura General Hospital, Kanagawa, JPN.
Kazuya KoizumiGastroenterology Medicine Center, Shonan Kamakura General Hospital, Kanagawa, JPN.
Haruki UojimaGastroenterology Medicine Center, Shonan Kamakura General Hospital, Kanagawa, JPN.
Karen KimuraGastroenterology Medicine Center, Shonan Kamakura General Hospital, Kanagawa, JPN.
Takashi NishinoGastroenterology Medicine Center, Shonan Kamakura General Hospital, Kanagawa, JPN.
Junichi TasakiGastroenterology Medicine Center, Shonan Kamakura General Hospital, Kanagawa, JPN.
Chikamasa IchitaGastroenterology Medicine Center, Shonan Kamakura General Hospital, Kanagawa, JPN.
Akiko SasakiGastroenterology Medicine Center, Shonan Kamakura General Hospital, Kanagawa, JPN.
Shonan Kamakura General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives Considering that pathogens resistant to initial antibiotic therapies for cholangitis can affect mortality rates, appropriate initial empiric antibiotic therapy is important. However, evidence regarding the influence of pathogens resistant to initial antibiotics in patients with cholangitis who have undergone early endoscopic retrograde cholangiopancreatography (ERCP) is limited, and the conditions in several cases can improve with early ERCP even when pathogens resistant to initial antibiotics are detected on time. Therefore, this study aimed to assess the influence of pathogens resistant to initial antibiotics on the course of cholangitis in patients undergoing early ERCP. Materials and methods Patients (n=266) with positive blood or bile culture results treated with early ERCP were divided into those with cultures that were resistant to the initial antibiotics (antibiotic-resistant group; n=66; 24.8%) and those with cultures that were sensitive to the initial antibiotics (antibiotic-sensitive group; n=200; 75.2%). The duration of hospitalization, in-hospital mortality rates due to cholangitis, rates of increased disease severity, and complications during hospitalization were studied. Results

Indexed as

antibacterial agentsantibiotic-resistant pathogenscholangitisendoscopic retrograde cholangiopancreatographypost-ercp cholecystitisrisk factors

Identifiers

PMID34650837
PMCPMC8487445
OpenAlexW3204388447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.